We are pleased to announce that our updated BPaL-L short regimen rifampicin-resistant TB (RR-TB) poster is now available with new monitoring recommendations. BPaL-L is an abbreviation for the treatment regimen containing bedaquiline (B), pretomanid (Pa), linezolid (L) and levofloxacin (L).

We have also made substantial revisions to the RR-TB adverse drug events poster. This includes incorporating pretomanid and revised management advice for drug-induced liver injury, haematological toxicity,peripheral neuropathy and QT interval prolongation.

Access the updated posters under Resources - Educational Material/Posters.